PAPILLARY CYSTADENOFIBROMA OF ENDOMETRIUM: A RARE CASE REPORT AND REVIEW OF THE LITERATURE

Saudamini Omprakash Sikchi, Michelle De Padua, Samatha Kumar

Abstract


In female genital tract, an adenofibroma is commonly reported in ovary and rarely in cervix while it is extremely rare in endometrium. Here, we report a case of papillary cystadenofibroma of uterus in a postmenopausal woman with history of breast carcinoma. In our review of published case reports, very few cases have been reported so far arising from endometrium, presenting as polypoidal lesions in uterine cavity. In all reported cases, six patients had history of breast carcinoma. There has been an attempt to establish relationship between adenofibroma of uterus and tamoxifen intake in patients with breast carcinoma. However, our patient did not receive tamoxifen. In a view of reported incidence of these tumours in breast cancer patients we propose a theory that uterine mixed Müllerian tumour may be secondary to yet unknown genetic risk factor independent of tamoxifen.


Keywords


cystadenofibroma, breast carcinoma, mullerian mixed tumour, tamoxifen

Full Text:

PDF

References


Zaloudek CJ, Maj Mc Usa, Norris HJ. Adenofibroma and adenosarcoma of the uterus: a clinicopathologic study of 35 cases. Cancer 1981; 48: 354-366.

Abell MR. Papillary adenofibroma of the uterine cervix. Am J Obstet Gynecol 1971; 110: 990-993.

Huang KT, Chen CA, Cheng WF, et al. Sonographic characteristics of adenofibroma of the endometrium following tamoxifen therapy for breast cancer: two case reports. Ultrasound Obstet Gynecol 1996; 7: 363-366.

Oshima H, Miyagawa H, Sato Y, et al. Adenofibroma of the endometrium after tamoxifen therapy for breast cancer: MR findings. Abdom Imaging 2002; 27: 592-594.

Ikuta A, Tanaka Y, Mizokami T, et al. Benign endometrial adenofibroma and polyp in patients receiving tamoxifen: findings on transvaginal ultrasonography and magnetic resonance imaging. J Med Ultrason 2005; 35: 71-76.

Shi H, Chen X, Lv B, et al. Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary. Int J Exp Pathol 2015; 8: 15381-15385.

Grimalt M, Arguelles A, Ferenczy A. Papillary cystadenofibroma of endometrium: a histochemical and ultrastructural study. Cancer 1975; 36: 137-144.

Wells M, Palacios J, Oliva E, Prat J. Mixed epithelial and mesenchymal tumours. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH. (eds). WHO classification of tumours of female reproductive organs, 4th edn. Lyon: IARC Press, 2014; 148-149.

Seltzer VL, Levine A, Spiegel G, Rosenfeld D, Coffey EL. Case report adenofibroma of the Uterus: multiple recurrences following wide local excision. Gynecol Obstet 1990; 37: 427-431.

Bettaieb I, Mekni A, Bellil K, et al. Endometrial adenofibroma: a rare entity. Arch Gynecol Obstet 2007; 275: 191-193.

Maciel R, Carvalho S, Teixeira M, Areias MJ. Adenofibroma in a young patient : a rare entity in an uncommon age. Case Rep Obstet Gynecol. Published online: 28 Dec 2013;DOI:10.1155/2013/308464.

Wilson BT, Cordell HJ. Uterine carcinosarcoma/malignant mixed Müllerian tumour incidence is increased in women with breast cancer, but independent of hormone therapy. J Gynecol Oncol 2015; 26: 249-251.

Ostor AG, Fortune DW. Benign and low grade variants of mixed Müllerian tumour of the uterus. Histopathology 1980; 4: 369-369.

Clement PB, Scully RE. Müllerian adenofibroma of the uterus with invasion of myometrium and pelvic veins. Int J Gynecol Pathol 1990; 9: 363-371.

Miller KN, McClure SP. Papillary adenofibroma of the uterus. Report of a case involved by adenocarcinoma and review of the literature. Am J Clin Pathol 1992; 97: 806-809.


Refbacks

  • There are currently no refbacks.